Heidelberg Pharma Aktie
2,86EUR | 0,08EUR | 2,88% |
WKN DE: A11QVV / ISIN: DE000A11QVV0
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 84 | 96 | 110 | 105 | 116 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,10 | 0,02 | 0,17 | 0,09 | 0,06 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 8 | 9 | 88 | 57 | 48 |
Summe Anlagevermögen | 12 | 13 | 13 | 14 | 13 |
Summe Aktiva | 20 | 22 | 101 | 70 | 61 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 7 | 15 | 34 | 21 | 30 |
Summe Eigenkapital | 13 | 7 | 67 | 49 | 31 |
Summe Passiva | 20 | 22 | 101 | 70 | 61 |
Adresse
Gregor-Mendel-Strasse 22, 68526 Ladenburg | |
Telefon | +49 (6209) 1009-0 |
Fax | +49 (6209) 1009-19 |
Internet | http://heidelberg-pharma.com |
Management
Andreas Pahl
Chief Executive Officer |
András Strassz
Chief Medical Officer |
Birgit Kudlek
Member-Supervisory Board |
Christof Hettich
Chairman-Supervisory Board |
Dong Zhou Liu
Member-Supervisory Board |
Friedrich von Bohlen und Halbach
Member-Supervisory Board |
Georg F. Baur
Deputy Chairman-Supervisory Board |
George Badescu
Chief Business Officer |
Jörg Kemkowski
Chief Operating Officer |
Mathias Hothum
Deputy Chairman-Supervisory Board |
Sylvia Wimmer
Director-Corporate Communications |
Walter Miller
Chief Financial Officer |
Yan Xia
Member-Supervisory Board |
Yvonne Halbig
Head-Human Resources |